Skip to content

COSMOS HEALTH INC.: 10-Q filed 2025-08-18

What COSMOS HEALTH INC. reported in its quarterly report filed 2025-08-18 (fiscal Q2 2025): 50 published measures, 144 facts as tagged in accession 0001477932-25-005997.

This filing

Form
10-Q (quarterly report)
Filed
2025-08-18
Fiscal period
fiscal Q2 2025
Accession
0001477932-25-005997 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All COSMOS HEALTH INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-06-3061,835,560USD
At 2024-12-3154,311,892USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-06-3035,603,926USD
At 2024-12-3129,778,963USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-06-3026,231,633USD
At 2025-03-3125,951,711USD
At 2024-12-3124,532,929USD
At 2024-06-3032,119,574USD
At 2024-03-3134,546,682USD
At 2023-12-3136,043,028USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-2,828,068USD91
2025-01-01 to 2025-06-30-3,646,165USD181
2024-04-01 to 2024-06-30-2,590,711USD91
2024-01-01 to 2024-06-30-4,457,401USD182

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2025-01-01 to 2025-06-30-1,396,236USD181
2024-01-01 to 2024-06-30-4,622,989USD182

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2025-01-01 to 2025-06-3035,064USD181
2024-01-01 to 2024-06-30116,826USD182

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2025-04-01 to 2025-06-3014,745,702USD91
2025-01-01 to 2025-06-3028,458,230USD181
2024-04-01 to 2024-06-3013,206,717USD91
2024-01-01 to 2024-06-3027,791,190USD182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2025-01-01 to 2025-06-302,165,227USD181
2024-01-01 to 2024-06-30746,610USD182

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2025-01-01 to 2025-06-3064,751USD181
2024-01-01 to 2024-06-30242,404USD182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-06-30-117,668,440USD
At 2024-12-31-114,022,275USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-04-01 to 2025-06-3028,753,492shares91
2025-01-01 to 2025-06-3027,403,053shares181
2024-04-01 to 2024-06-3017,834,023shares91
2024-01-01 to 2024-06-3017,025,203shares182

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-04-01 to 2025-06-3028,753,492shares91
2025-01-01 to 2025-06-3027,403,053shares181
2024-04-01 to 2024-06-3017,834,023shares91
2024-01-01 to 2024-06-3017,025,203shares182

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-0.1USD/shares91
2025-01-01 to 2025-06-30-0.13USD/shares181
2024-04-01 to 2024-06-30-0.15USD/shares91
2024-01-01 to 2024-06-30-0.26USD/shares182

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-0.1USD/shares91
2025-01-01 to 2025-06-30-0.13USD/shares181
2024-04-01 to 2024-06-30-0.15USD/shares91
2024-01-01 to 2024-06-30-0.26USD/shares182

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2025-04-01 to 2025-06-300USD91
2025-01-01 to 2025-06-300USD181
2024-04-01 to 2024-06-300USD91
2024-01-01 to 2024-06-300USD182

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2025-06-3010,820,391USD
At 2024-12-319,689,505USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2025-01-01 to 2025-06-301,159,632USD181
2024-01-01 to 2024-06-30680,389USD182

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-2,645,319USD91
2025-01-01 to 2025-06-30-3,478,464USD181
2024-04-01 to 2024-06-30-2,502,026USD91
2024-01-01 to 2024-06-30-4,338,134USD182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-06-3030,562,311USD
At 2024-12-3125,461,347USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2025-04-01 to 2025-06-30388,814USD91
2025-01-01 to 2025-06-30575,921USD181
2024-04-01 to 2024-06-30342,446USD91
2024-01-01 to 2024-06-30511,118USD182

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-06-3031,166,561USD
At 2024-12-3125,757,540USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2025-06-3049,697USD
At 2024-12-3149,697USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2025-06-307,820,464USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2025-06-3015,455,787USD
At 2024-12-3113,478,263USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-04-01 to 2025-06-303,809,133USD91
2025-01-01 to 2025-06-306,692,077USD181
2024-04-01 to 2024-06-303,269,274USD91
2024-01-01 to 2024-06-306,439,008USD182

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2025-06-305,110,947USD
At 2024-12-314,355,365USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2025-04-01 to 2025-06-301,163,814USD91
2025-01-01 to 2025-06-303,213,613USD181
2024-04-01 to 2024-06-30767,248USD91
2024-01-01 to 2024-06-302,100,874USD182

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2025-04-01 to 2025-06-3074,637USD91
2025-01-01 to 2025-06-3090,266USD181
2024-04-01 to 2024-06-300USD91
2024-01-01 to 2024-06-300USD182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-06-3029,717,802shares
At 2024-12-3123,602,638shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2025-06-30655,503USD
At 2024-12-31315,105USD
At 2024-06-30343,509USD
At 2023-12-313,833,195USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2025-06-30144,328,641USD
At 2024-12-31141,583,625USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2025-06-30458,807USD
At 2024-12-31-2,134,931USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2025-06-30670,302USD
At 2024-12-31696,166USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2025-06-305,190,505USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2025-06-3012,480,745USD
At 2024-12-3110,964,535USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2025-06-301,660,354USD
At 2024-12-311,275,030USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2025-06-308,175,664USD
At 2024-12-317,706,837USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2025-06-301,233,607USD
At 2024-12-311,108,484USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2025-06-301,930,066USD
At 2024-12-311,959,193USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2025-06-301,637,553USD
At 2024-12-311,310,388USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-2,828,068USD91
2025-01-01 to 2025-06-30-3,646,165USD181
2024-04-01 to 2024-06-30-2,590,711USD91
2024-01-01 to 2024-06-30-4,457,401USD182

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-2,828,068USD91
2025-01-01 to 2025-06-30-3,646,165USD181
2025-01-01 to 2025-03-31-818,097USD90
2024-04-01 to 2024-06-30-2,590,711USD91
2024-01-01 to 2024-06-30-4,457,401USD182
2024-01-01 to 2024-03-31-1,866,690USD91

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-1,265,598USD91
2025-01-01 to 2025-06-30-1,052,427USD181
2024-04-01 to 2024-06-30-2,767,302USD91
2024-01-01 to 2024-06-30-5,233,268USD182

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2025-04-01 to 2025-06-301,490,485USD91
2025-01-01 to 2025-06-302,969,187USD181
2024-04-01 to 2024-06-301,390,525USD91
2024-01-01 to 2024-06-302,808,663USD182

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2025-04-01 to 2025-06-30249,811USD91
2025-01-01 to 2025-06-30458,644USD181
2024-04-08 to 2024-06-30193,518USD84
2024-01-01 to 2024-06-30383,373USD182

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-42,190USD91
2025-01-01 to 2025-06-30-110,327USD181
2024-04-01 to 2024-06-30-29,305USD91
2024-01-01 to 2024-06-30162,519USD182

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-182,749USD91
2025-01-01 to 2025-06-30-167,701USD181
2024-04-01 to 2024-06-30-88,685USD91
2024-01-01 to 2024-06-30-119,267USD182

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2025-01-01 to 2025-06-30380,227USD181
2024-01-01 to 2024-06-30512,966USD182

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-06-30123,992USD181
2024-01-01 to 2024-06-30-788,013USD182

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-06-30157,650USD181
2024-01-01 to 2024-06-30-323,436USD182

Inspect the source

Entity
COSMOS HEALTH INC. / CIK 0001474167
Captured
2026-09-20T09:07:57.368Z
SEC response SHA-256
f91884dcfc5ed49a155a49d6e8abdd1a5d8586cbb0334ac226e4561bd32d019e

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001474167.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))